Deep Learning for Drug-Induced Liver Injury
By Youjun Xu, Ziwei Dai, Fangjin Chen, Shuaishi Gao, Jianfeng Pei, Luhua Lai. Journal of Chemical Information and Modeling, 2015
324 citations recorded by the source corpus.
Subfields: Computational Theory and Mathematics, Molecular Biology, Pharmacology
View Paper: https://www.semanticscholar.org/paper/db0f059b80acd2e9e494f42b49c8e6066294866a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Computational Theory and Mathematics
- Charles Siegel
- Abhinav Vishnu
- Garrett B. Goh
- Nathan Oken Hodas
- Marinka Zitnik
- Tianfan Fu
- Jimeng Sun
- Shyue Ping Ong
In Molecular Biology
- Charles Siegel
- Marinka Zitnik
- Abhinav Vishnu
- Garrett B. Goh
- Nathan Oken Hodas
- Kexin Huang
- Jure Leskovec
- Cao Xiao
In Pharmacology
Citations in the corpus
- Chemception: A Deep Neural Network with Minimal Chemistry Knowledge Matches the Performance of Expert-developed QSAR/QSPR Models (2017, methodology): “These human-expert features are then used by machine learning algorithms for QSAR and QSPR modeling, which in recent years have also included deep neural networks.(9-23) However, we observed that even in the most recent chemistry literature, deep learning in chemistry still falls under this traditio”
- Recent advances and applications of deep learning methods in materials science (2021, methodology): “DL for molecular materials have been used to predict technologically important properties such as aqueous solubility [135] and toxicity [136].”
- Deep Learning and Medical Diagnosis: A Review of Literature (2018, unknown): “[28] UGRNN Various medical data sets Drug-induced liver injury (DILI) prediction.”
- Development and evaluation of a deep learning model for protein–ligand binding affinity prediction (2017, methodology): “…of deep learning methods have also been shown for computer-aided drug de-sign (CADD) (Lusci et al. , 2013; Dahl et al. , 2014; Ma et al. , 2015; Xu et al. , 2015; Duvenaud et al. , 2015; Kearnes et al. , 2016; Jastrz¸ebski et al. , 2016; Segler et al. , 2017; Olivecrona et al. , 2017;…”
- The rise of deep learning in drug discovery. (2018, methodology): “[47] applied the same method to model drug-induced liver injury (DILI).”
- Computational Protein Design with Deep Learning Neural Networks (2018, methodology): “…Particularly in computational biology/chemistry, it has been used in protein-ligand scoring, 40-42 protein-protein interaction prediction, 43 protein secondary structure prediction, 44-49 protein contact map prediction, 50-52 and compound toxicity 53,54 and liver injury prediction, 55 among others.”
- Therapeutics Data Commons: Machine Learning Datasets and Tasks for Drug Discovery and Development (2021, methodology): “This dataset is aggregated from U.S. FDA’s National Center for Toxicological Research and is collected from Xu et al. (2015).”